SEC Comment Letter for INOVIO PHARMACEUTICALS, INC. (INO) (CIK 0001055726) (INO) — May 1, 2020

INOVIO PHARMACEUTICALS, INC. (INO) (CIK 0001055726)
Date: May 1, 2020 · CIK: 0001055726 · Accession: 0000000000-20-003771

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-14888

Date

May 1, 2020

Author

Not clearly detected

Form

UPLOAD

Company

INOVIO PHARMACEUTICALS, INC. (INO) (CIK 0001055726)

Letter

United States securities and exchange commission logo May 1, 2020 Peter Kies Chief Financial Officer INOVIO PHARMACEUTICALS, INC. 660 W. GERMANTOWN PIKE, SUITE 110 PLYMOUTH MEETING, PA 19462 Re:INOVIO PHARMACEUTICALS, INC. Form 10-K for the Fiscal Year Ended December 31, 2019 File No. 001-14888 Filed March 12, 2020 Dear Mr. Kies: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
May 1, 2020
Peter Kies
Chief Financial Officer
INOVIO PHARMACEUTICALS, INC.
660 W. GERMANTOWN PIKE, SUITE 110
PLYMOUTH MEETING, PA 19462
Re:INOVIO PHARMACEUTICALS, INC.
Form 10-K for the Fiscal Year Ended December 31, 2019
File No. 001-14888
Filed March 12, 2020
Dear Mr. Kies:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io